We pride ourselves on our scientific innovation, strategic multidisciplinary approach, flexibility to client needs, and tech-enabled solutions to pharmaceutical, biotech, and medical device companies across the product lifecycle. Our unrivalled knowledge in advanced analytics, robust methods and strategic innovation in research sets us apart. With expertise harnessing the power of data across a diverse array of international geographies, we balance scientific rigor with commercial awareness to provide you with the evidence you need to launch new products, overcome regulatory hurdles and achieve payer approval.
HEOR & RWE
Cytel is a Global HEOR & RWE consultancy with a team of over 200+ consultants located in Europe, North America, and Asia-Pacific.
Global HEOR Solutions
Cytel’s experts in Health Economic Outcomes Research (HEOR) generate evidence-based cost-effectiveness models that showcase the true economic value of your product. We specialize in innovative HEOR solutions that strengthen your market access plan, health economic modeling, HEOR value communications, and other standard models of pharmaceutical modeling for comparative effectiveness research.
Global RWE Solutions
Cytel’s experts in Real World Evidence (RWE) use advanced quantitative techniques to prepare sponsors for successful regulatory and payer outcomes. We have supported reimbursement submissions in 26 countries across 40 indications, and draw on the experience of leading experts across the world.